Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Treatment with androgen receptor inhibitors was associated with a higher likelihood of falls and fractures.
FDA approves Nubeqa for nonmetastatic prostate cancer
The androgen receptor inhibitor delayed cancer metastasis in a late-stage clinical trial.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.